Literature DB >> 18585361

SnapShot: Ras Signaling.

Megan Cully1, Julian Downward.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18585361     DOI： 10.1016/j.cell.2008.06.020

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  30 in total

1.  Measurement of constitutive MAPK and PI3K/AKT signaling activity in human cancer cell lines.

Authors:  Kim H T Paraiso; Kaisa Van Der Kooi; Jane L Messina; Keiran S M Smalley
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

2.  RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.

Authors:  Wei Guo; Cong Wang; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2015-01-13       Impact factor: 5.150

3.  Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.

Authors:  Nathan T Ihle; Lauren A Byers; Edward S Kim; Pierre Saintigny; J Jack Lee; George R Blumenschein; Anne Tsao; Suyu Liu; Jill E Larsen; Jing Wang; Lixia Diao; Kevin R Coombes; Lu Chen; Shuxing Zhang; Mena F Abdelmelek; Ximing Tang; Vassiliki Papadimitrakopoulou; John D Minna; Scott M Lippman; Waun K Hong; Roy S Herbst; Ignacio I Wistuba; John V Heymach; Garth Powis
Journal:  J Natl Cancer Inst       Date:  2012-01-13       Impact factor: 13.506

4.  PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression.

Authors:  Kim H T Paraiso; Yun Xiang; Vito W Rebecca; Ethan V Abel; Y Ann Chen; A Cecilia Munko; Elizabeth Wood; Inna V Fedorenko; Vernon K Sondak; Alexander R A Anderson; Antoni Ribas; Maurizia Dalla Palma; Katherine L Nathanson; John M Koomen; Jane L Messina; Keiran S M Smalley
Journal:  Cancer Res       Date:  2011-02-11       Impact factor: 12.701

5.  Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer.

Authors:  Amanda J Redig; Marzia Capelletti; Suzanne E Dahlberg; Lynette M Sholl; Stacy Mach; Caitlin Fontes; Yunling Shi; Poornima Chalasani; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

6.  Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells.

Authors:  Y Wang; V N Ngo; M Marani; Y Yang; G Wright; L M Staudt; J Downward
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

7.  Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.

Authors:  Michelle Cicchini; Elizabeth L Buza; Kyra M Sagal; A Andrea Gudiel; Amy C Durham; David M Feldser
Journal:  Cell Rep       Date:  2017-02-21       Impact factor: 9.423

8.  Akt1 deletion prevents lung tumorigenesis by mutant K-ras.

Authors:  M C Hollander; C R Maier; E A Hobbs; A R Ashmore; R I Linnoila; P A Dennis
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

9.  Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck.

Authors:  Hongguang Guo; Hongliang Liu; Jianhua Wei; Yangkai Li; Hongping Yu; Xiaoxiang Guan; Wang Li-E; Guojun Li; Erich M Sturgis; Qingyi Wei; Zhensheng Liu
Journal:  Eur J Cancer       Date:  2013-11-29       Impact factor: 9.162

Review 10.  Change or die: targeting adaptive signaling to kinase inhibition in cancer cells.

Authors:  Vito W Rebecca; Keiran S M Smalley
Journal:  Biochem Pharmacol       Date:  2014-08-12       Impact factor: 5.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.